華榮股份(603855.SH)擬5000萬元參與設立瑞信基金
格隆匯4月8日丨華榮股份(603855.SH)公佈,為提升綜合競爭力和可持續發展能力,藉助外部投資機構優勢,公司擬參與設立景寧懷格瑞信創業投資合夥企業(有限合夥)(暫定名,以工商部門核准為準,以下簡稱“瑞信基金”),並由公司關聯方寧波懷格健康投資管理合夥企業(有限合夥)(以下簡稱“懷格健康”)擔任基金管理人。投資領域為醫療器械、生物製藥、醫療服務及醫療醫藥外包服務等企業股權。
公司擬作為有限合夥人出資人民幣5000萬元;懷格健康擬作為普通合夥人(單獨或聯合其關聯方)出資不低於基金認繳出資總規模的1%,即不低於人民幣300萬元;上海康德萊醫療器械股份有限公司(以下簡稱“康德萊”)作為有限合夥人意向出資人民幣5000萬元;剩餘有限合夥出資份額由基金管理人懷格健康向符合要求的其他合格投資者募集完成。各合夥人均以貨幣資金方式出資。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.